Azitra, Inc. (NYSEAMERICAN:AZTR) Short Interest Update

Azitra, Inc. (NYSEAMERICAN:AZTR) saw a significant decrease in short interest in the month of August. As of August 14th, there was short interest totaling 20,858 shares, a decrease of 86.5% from the July 30th total of 154,671 shares. Based on an average trading volume of 2,242,858 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the shares of the company are sold short.

Azitra Trading Up 12.3%

AZTR stock traded up $0.02 on Wednesday, reaching $0.18. 2,596,560 shares of the company were exchanged, compared to its average volume of 9,660,498. Azitra has a 12 month low of $0.10 and a 12 month high of $1.36. The stock’s fifty day moving average price is $0.15 and its 200 day moving average price is $0.19.

Azitra (NYSEAMERICAN:AZTR) last issued its quarterly earnings results on Wednesday, August 12th. The company reported ($0.17) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.05). As a group, sell-side analysts predict that Azitra will post -0.25 EPS for the current year.

About Azitra

Azitra Inc is a clinical-stage biopharmaceutical company focused on developing live bacterial therapies for dermatological conditions. Headquartered in Cambridge, Massachusetts, the company leverages its proprietary ActoBiotic platform to formulate topical treatments that aim to modulate the skin’s native microbial ecosystem.

The company’s lead investigational therapies are being evaluated in early-phase clinical studies for inflammatory skin disorders, including atopic dermatitis and other conditions characterized by microbial imbalance.